These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049 [TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
5. Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies. Prieto GA; Cabral AR; Zapata-Zuñiga M; Simón AJ; Villa AR; Alarcón-Segovia D; Cabiedes J Arthritis Rheum; 2003 Feb; 48(2):471-4. PubMed ID: 12571857 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
8. Val/Leu247 polymorphism of beta2-glycoprotein I in Brazilian patients with antiphospholipid syndrome--a genetic risk factor? Pernambuco-Climaco JM; Brochado MJ; Freitas MV; Roselino AM; Louzada-Junior P Ann N Y Acad Sci; 2009 Sep; 1173():509-14. PubMed ID: 19758193 [TBL] [Abstract][Full Text] [Related]
9. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815 [TBL] [Abstract][Full Text] [Related]
10. Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis. Lee YH; Choi SJ; Ji JD; Song GG Lupus; 2012 Jul; 21(8):865-71. PubMed ID: 22399073 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies in arterial thrombosis. Koike T Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978 [TBL] [Abstract][Full Text] [Related]
12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A; Kickler TS; Petri M J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. de Laat B; Mertens K; de Groot PG Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765 [TBL] [Abstract][Full Text] [Related]
16. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [TBL] [Abstract][Full Text] [Related]
17. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Domenico Sebastiani G; Minisola G; Galeazzi M Autoimmun Rev; 2003 Oct; 2(6):387-94. PubMed ID: 14550881 [TBL] [Abstract][Full Text] [Related]
18. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817 [TBL] [Abstract][Full Text] [Related]
19. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [TBL] [Abstract][Full Text] [Related]